Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short versus extended carbapenem therapy for unexplained neutropenic fever in hematology patients
NL-OMON26213Not yet recruiting
- Sponsor
- VU university medical center
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of imipenem + cilastatin and meropenem in febrile neutropenia (FN) and hematopoietic malignancies (2 arms), sponsored by VU university medical center. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
imipenem + cilastatinmeropenem
03
Conditions
febrile neutropenia (FN)hematopoietic malignancies
Beyond the preview
Go deeper on NL-OMON26213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26213.